Inc. (Chindex)* is a leading American company in the healthcare
sectors of the Chinese marketplace, including Hong Kong. Founded
in 1981, the Company has accumulated unique executive management
expertise in China trade and a dominant competitive position in
its healthcare market sectors.
Chindex is an
American public company traded on the NASDAQ stock exchange. It
is a New York corporation with company headquarters located in the
Washington, D.C. metropolitan area. Chindex has over 400 employees
worldwide, most of whom reside in China and Hong Kong. In China,
Chindex operates three representative offices, three subsidiary
companies, and two joint ventures.
business activities are conducted in China including Hong Kong.
Revenues are generated from the sale of healthcare products and
the provision of healthcare services. On the basis of exclusive
agreements, Chindex markets, sells, and facilitates the export of
select capital healthcare equipment and instrumentation to China.
It is the largest independent U.S. distributor of healthcare equipment
in China. Through a network of wholly foreign-owned subsidiaries,
the Companys Products Distribution business imports and distributes
off-the-shelf healthcare instrumentation and consumable products.
Healthcare services revenue is generated through the Companys
private hospital, Beijing United Family Hospital.
The Chindex growth plan includes continuing expansion of the capital
medical equipment and instrumentation business, rapid expansion
of the Products Distribution product portfolio, with an emphasis
on increasing the number and variety of products that are sold directly
to retail pharmacies, and the development of a network of private
family hospitals, based on the Beijing United Family Hospital model,
to serve Chinas growing middle class.
U.S.-China Industrial Exchange, Inc. has long
been known as "Chindex," its original
telex address acronym from the early 1980s.
Beginning in 1998, the Company formally began
doing business as Chindex International, Inc.,
although its legal name remains U.S.-China
Industrial Exchange, Inc.